Bengaluru-based medtech startup Cureous Labs, founded by Asish Mohandas, has raised ₹1.66 crore in seed funding led by Inflection Point Ventures (IPV) with participation from Anthill Ventures. This round provides a strong push for the company’s mission of making elderly care affordable and impactful through innovative medical technologies.
Funding for Scale and Impact
The new funding will be deployed across several strategic initiatives:
-
Manufacturing the first batch of Eturnal™, the company’s flagship product—an automated patient repositioning system designed to prevent pressure injuries while reducing caregiver strain.
-
Building inventory and scaling operations to serve hospitals, rehabilitation centers, and home-care environments.
-
Establishing a disinfection center and securing global-standard safety certifications.
-
Expanding its product portfolio to cater to B2B healthcare clients across India.
Eturnal™: Affordable Healthcare That Cares
What sets Cureous Labs apart is its commitment to affordability without compromise. Eturnal™ delivers advanced pressure relief at just one-fifth the cost of international alternatives. For a market like India—where accessibility is often the biggest barrier—this pricing model ensures that high-quality medtech is available to those who need it most.
The impact is already visible. To date, Eturnal™ has logged over 30,000 hours of use and performed 14,000+ automated patient turns across hospitals, rehabilitation centers, and home setups. By actively reducing the risk of pressure injuries, it’s becoming a lifeline technology for both patients and caregivers.
Building for a Large Market Need
India faces a significant healthcare challenge with over 154 million individuals bedridden and vulnerable to pressure injuries. By addressing this gap, medtech startup Cureous Labs is creating a product that goes beyond innovation—it’s delivering dignity, safety, and independence for the elderly and immobile.
Founder and CEO Asish Mohandas emphasizes this vision: “Our mission goes beyond building a product. We’re empowering independent living through technology that cares.” With IPV’s early confidence, Cureous Labs now has the runway to build a category-defining brand in medtech and elderly care.
The Bigger Picture
At Startup Veda, we spotlight founder-led deep-tech and medtech ventures that blend innovation with real-world impact. The journey of Cureous Labs is a reminder that India’s healthcare future isn’t just about technology—it’s about making care accessible, affordable, and human-centered.
👉 Want to follow the next wave of healthcare and age-tech innovation?
✨ Follow Startup Veda for authentic storytelling, smart funding moves, and innovations that matter.
